hotspot -WSS

hotspot

author：explore 2025-08-26 10:55:44 - browse：87755

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications.

The medicine, danuglipron, met its primary target in a placebo-controlled Phase 2b trial, leading to a statistically significant amount of weight lost, the company said. But the weight reductions were smaller than those seen in trials of rival medicines targeting the same GLP-1 pathway, and a high rate of patients experienced side effects and dropped out of the trial.

Pfizer said it would not move twice-daily danuglipron into Phase 3 trials, but that instead it would focus on a once-daily formulation, which is currently undergoing pharmacokinetic studies. Data are expected in the first half of 2024.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： A new study sees potential in DNA sequencing of infants

hotspot

WSS

Chinese researcher claims birth of first gene

NIH fellows want a pay raise. Will that mean less money for grants?

Petition to FDA: Get the lead out of consumer hair dyes

Cancer, immunology, HIV research ensnared in fetal tissue politics

Pregnancy ages women, but effects reverse after delivery

This gene therapy has record $4.25 million price. It's saved children.

focus

hotspot

knowledge

Guidelines to prevent youth baseball injuries need more muscle

CRISPR technology availability, affordability needs to be expanded

Drug repurposing or repositioning? The language matters

Living with Fabry disease, a condition that causes chronic pain

Anesthesiologist group: stop taking Ozempic before surgery

Iowa House, Senate pass 6

Medical records are filled with copy

'Patient friction coefficient' can gauge a clinical trial's patient burden

How to save PrEP access — and even expand it

What Kate Middleton's cancer revelation might teach the world

hotspot

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Lecanemab for Alzheimer's is coming. Is the health system ready?

HCA discloses massive data breach affecting 11 million patients

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

California’s proposed $25 per hour health care minimum wage

hotspot

hotspot

explore

explore